Health Condition 1: null- ASA I and II patients scheduled for elective laparoscopic surgeries
Conditions
Interventions
Intervention1: Group E - Study Group
Esmolol group: The study group received Inj. Esmolol 1mg/kg bolus diluted to 20ml followed by
an infusion dose of 0.05mg/kg/min diluted to 30ml taken in a 50 ml sy
Sponsors
Dr Shweta Nayak
Eligibility
Inclusion criteria
Inclusion criteria: 1)ASA 1 and 2 patients 2)Patients who are scheduled to undergo elective laparoscopic surgeries under general anaesthesia 3)Patients aged between 18-70 years 4)Patients weighing between 40-80kgs
Exclusion criteria
Exclusion criteria: 1)Uncontrolled hypertension (DBP >100 inspite of treatment) 2)Uncontrolled Diabetes and or (HbA1c > 6) 3)Beta blocker therapy 4)Any Cardiac ailments 5)Renal disease 6)Asthma 7)Severe haemodynamic instability 8)Pregnancy 9)Known allergy to any drug used in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative requirement of Fentanyl, Desflurane and Rocuronium Haemodynamic stabilityTimepoint: Intraoperative and 30 minutes postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative nausea vomiting Pain Intraoperative awarenessTimepoint: 30 minutes postoperative period | — |
Countries
India
Contacts
Public ContactDr Ujjwalraj Dudhedia
Dr. Lakhumal Hiranand Hiranandani Hospital
Outcome results
None listed